Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement. . Neuro Oncol 2024 Aug 21:noae151. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement. Neuro Oncol 2024 Aug 21:noae151. doi: 10.1093.
PMID: 39167705